Myopia Fund Program

Myopia Fund Program is sponsored by Fondation des maladies de l'oeil (FMO) / Vision Science Research Network (VSRN). This program is an initiative of the Fondation des maladies de l'oeil (FMO) and aims to fund research projects to understand, prevent, and treat myopia.

Myopia fund - Vision Network Funding> Grants for researchers Communication with People who are Deafblind Learning, Education, and Support of Deafblind Children and Adults Stereo olfaction underlies stable coding of head direction in blind mice RESEARCH GRANT INITIATED BY THE FONDATION DE MALADIES DE L’OEIL This program aims to fund promising high-risk/high-reward research initiatives on myopia.

In line with its mission, the Fondation des maladies de l’œil (FMO) aims to fund projects requiring seed money to get projects off the ground and make them competitive with major federal agencies (e.g., CIHR/CIHR). The principal researcher in Quebec must meet the definition of independent researcher, as formulated by the FRQS. This grant is for a period of one (1) year ( one renewal possible – progress described in Section 9).

Please see the documentation for full details. * If these dates fall on a Friday, Saturday or Sunday, the candidate will have until Monday evening to send their application to the VSRN. Myopia Fund PDF Version May 2026 Myopia Fund Word Version May 20256 A scientific report must be submitted at the end of each grant.

For any project financed by the VSRN, a financial report must be submitted to the FRQS at the end of the financial year (March 31) following the year of award as well as at the end of the grant.

2025-2026 Funded Researchers Clinician and Associate Professor Centre universitaire d’ophtalmologie, Hôpital Maisonneuve – Rosemont, Université de Montréal Domain : Clinical Research Grant Title: Effect of Secondary Treatment of Peripheral Avascular Retina on Myopia in Children With or Without Prior Anti-VEGF for Retinopathy of Prematurity SUMMARY : Retinopathy of prematurity (ROP) is an eye disease that affects babies born very early, before 30 weeks of gestation.

If not monitored and treated, it can lead to vision loss. Thanks to new medications called anti- VEGF agents, it is now possible to better preserve the structure of the eye in these children. However, even after treatment, certain areas at the periphery of the retina may remain without active, normal blood vessels.

This raises an important clinical question: Should these areas be treated with laser later on to prevent complications such as retinal detachment, or is it better to leave them untreated to avoid interfering with the natural growth of the eye, as treatment by laser may lead to the development of myopia (nearsightedness)?

This study will involve 100 children followed at CHU Sainte-Justine and Hôpital Maisonneuve-Rosemont, divided into four groups based on the treatment received at birth and whether or not they later underwent laser treatment to the peripheral retina. The objective is to compare vision, eye shape, and retinal structure across the groups.

We will use advanced imaging techniques to better understand the relationship between treatment and the development of myopia. This project will help guide future decisions regarding the followup and treatment of these children, with the goal of preserving long-term vision.

CRCHU de Québec – Université Laval Grant Title: Photobiomodulation for the treatment of myopia: mechanistic understanding SUMMARY : The myopia epidemic is progressing at an alarming rate, and it is important to focus our efforts on finding preventive and curative treatments for this disease. It has recently been shown that repeated exposure to a red light in a clinical setting slows the progression of myopia.

However, the mechanisms involved remain misunderstood, and this understanding is necessary to assess the risk of this treatment and to better personalize and optimize it. The objective of our project is to better understand the mechanisms involved in the effect of red light on myopia.

The development of tools to delay the progression of myopia is an emerging field of research, but advances are often fortuitous, and evidence of efficacy or convincing mechanisms are questionable. There is an important need for basic research on the subject to understand the mechanisms involved in its progression.

Our work represents the beginning of an initiative on the molecular understanding of myopia and preventive/curative treatment. We are in the early stages of understanding the mechanisms of red light effects on myopia. It is a wonderful problem because everything remains to be done, but it is also challenging because we are facing the unknown.

This is just the beginning of a research topic in which we could be pioneers and worldwide leaders. Communication with People who are Deafblind Communication with People who are Deafblind Assessment and Intervention Oxford University Press / Academic, ISBN: 9780192887177 Marleen J.

… Program for financing a scientific event Program for financing a scientific event This funding aims to provide financial support to members of the Network… Pilot project program for early-career investigators Pilot project program for early-career investigators This program was created to support early career vision investigators and vision… National and international networking program National and international networking program The objective of this program is to promote collaborations outside Quebec in order…